NADROPARIN clinical trials

Reduced anticoagulation targets in extracorporeal life support

This study looks at using lower doses of blood-thinning medicines like Heparin and Nadroparin for people on a life support machine called ECMO. It aims to see if this can reduce serious bleeding or blood clots and improve patient survival rates.